Speaker Biographies

Humberto C. Antunes is an entrepreneur in healthcare and wellness. He has an active involvement in research to address needs in skin health, the issues arising from the ageing demographics, providing advanced health solutions, helping technologies converge and participating in the digital transformation of healthcare. He led Galderma, a pharmaceutical company, for almost 20 years. Humberto created new distribution channels, acquired new audiences, and led many successful acquisitions, integrations, joint-ventures, license deals and divestitures. Humberto led research teams on both sides of the Atlantic that developed raw materials, new drug substances, medical devices and achieved hundreds of New Drug Applications, patent filings and clinical trials. Under Humberto’s leadership, Galderma went from a pure prescription drug player in the US and France in the late 90s to a global dermatology company with well-balanced businesses in aesthetic medicine, prescription drugs and a thriving skin care consumer segment. He further promoted Galderma’s geographic expansion to over 70 countries. An active member of the American Academy of Dermatology, he is also an honorary member of the International Society of Dermatology, an active member of the Women’s Dermatologic Society, and he currently serves as a Board member of the American Skin Association, where he also serves a chair of the Education Council. Humberto speaks, lectures, and serves in different functions at several innovation fora, incubators and conferences in skin health. He is a partner at Gore Range Capital since 2017, where he screens, helps finance, and advances innovation in skin health projects. Humberto’s experience spans the globe, with positions that took him and his family through many countries. He speaks six languages fluently. He graduated in Business Administration from the University of Nebraska – Lincoln and the IMD Lausanne, Switzerland.

Caitlin Blanche is a seasoned litigator who focuses her practice on consumer class action and product-focused litigation. Caitlin represents the manufacturers and distributors of food and beverages, cosmetics, pharmaceuticals, and medical devices in matters involving product issues such as false advertising, unfair competition, or other fraud-based claims, as well as product liability claims, including under California’s Proposition 65. She is nationally recognized as a thought leader in the environmental social governance (ESG) space, including greenwashing challenges, and is actively involved in efforts to combat “greenhushing.” Caitlin is a passionate advocate for business-oriented solutions to her client’s challenges and enjoys working with clients to manage needs across a multidisciplinary platform. Caitlin is often tasked with managing her clients’ most complex business litigation matters, both offensively and defensively. These matters often revolve around breach of contract concerns, trade secret and other brand protection priorities, interference, defamation, and real estate. She spends much of her time doing proactive work with her clients, advising them on best practices for avoiding litigation, including by thoughtful review and guidance related to product labeling, marketing, and vendor relationships. Caitlin has a deep knowledge of the law most relevant to consumer-facing communications, including challenges posed by social media and artificial intelligence. She stays on top of litigation trends and their catalysts, including angles like emerging contaminants, stigmatic ingredients, and ESG-related claims. As a result, Caitlin is a thought leader in consumer class action litigation, often predicting waves of litigation before they hit and preparing for the best defense possible, making her an informed and thoughtful partner to clients. Caitlin is an experienced public speaker, well known for her presentations on various aspects of litigation risk, including the often-overlooked risks of email. Clients turn to her to mitigate the dangers of their advertising and communication, to audit their internal and external communication systems, and to help prepare for legal processes such as subpoenas, depositions, and trial. She is very passionate about pro bono work, taking active roles in several projects annually.

Dan brings more than 30 years of executive experience across healthcare and consumer businesses. Proven track record of advancing highly potent molecules, novel formulations, and new routes of administration to address major unmet needs across multiple disease and aging conditions. Currently President & CEO of Tasman Therapeutics, Inc, a late-stage biopharma company developing novel products to treat mental health disorders. Tasman's lead oral drug product in Phase 3 is engineered to achieve a rapid, robust and durable antidepressant efficacy without dissociation, enabling at-home administration, improved patient outcomes, and expanded patient access to care. Currently serve on the Board of Directors of Galderma AG, AVAVA, Fount Bio, Yuva Biosciences and the Lieber Institute for Brain Development at John Hopkins. Co-Founder and former President & CEO of Revance Therapeutics, Inc. (acquired by Crown in 2025), from the company's inception in 2002 through IPO and BLA filing and subsequent approval of DAXXIFY. Recognized for changing the neuromodulator competitive landscape from the discovery and development of DAXXIFYâ„¢ the first and only FDA approved long-acting protein/peptide neuromodulator for the treatment of dermatologic and neurologic conditions. Prior to Revance, spent 15 years at W.L. Gore & Associated leading the development of market-leading surgical and interventional products.

Aaron Burton currently serves as Chief Executive Officer of Sciton and has worked at the company for more than 14 years. He began his career at Sciton in 2011, holding several leadership roles in sales, women's health, and operations before becoming CEO in 2020. Today, Aaron leads the company's global strategy and helps guide its culture and focus on improving people's lives. He works closely with teams across the company and leads with Sciton's values and credo. His focus is on building strong teams, reliable technology platforms, and durable long-term growth in the fast-changing aesthetics industry.

Tara Capalbo is an accomplished biopharmaceutical leader with 25 years of commercial experience across pharmaceuticals, medical device, buy and bill, at large global Fortune 500 organizations and at smaller privately held companies. She has an illustrious track record launching new products and new campaigns that accelerate growth, extend life cycles, and build markets. She recently started at Galderma as Head of US Aesthetics team. In her previous role, she led the commercial teams for the Glaucoma and the Ocular Surface Disease Eye Care businesses at AbbVie, which includes a surgical team, a buy and bill team as well as a traditional pharmaceutical team. Prior to this role she was Vice President of Marketing for BOTOX Therapeutic, leading an inline team of marketers across all indications of therapeutic BOTOX as well as pipeline strategy for toxins. During her tenure at AbbVie/ Allergan, she has led the successful launch of 6 products/ new indications across glaucoma, overactive bladder, spasticity, migraine and cerebral palsy, emphasizing best in class, innovative training, DTC optimization and patient access and support. Tara is committed to advancing women in leadership and is currently Co-Chair of Women Leaders of Octane and was previously awarded the HBA Luminary award. In addition, she is passionate about improving patient outcomes and is currently on the Advisory Board for the UCI Center for Health Care Management and Policy, on the American Glaucoma Foundation Advisory Board, has served on the Urology Care Foundation board and has partnered closely with patient advocacy and education groups including the Dystonia Medical Research Foundation, the National Headache Foundation and the American Migraine Foundation. She has an undergraduate degree in Human Biology from Stanford University and a MBA from UCLA Anderson School of Management.

Accomplished surgeon, educator, suthor and speaker Laurie A. Casas, MD, will be the recipient of The Aesthetic Foundation’s 2024 Career Achievement Award. The presentation will take place on Saturday, May 4 during The Aesthetic Meeting 2024 in Vancouver. Dr. Casas, the first woman to serve as Foundation President (2009-2010), will also be the first woman to receive this prestigious honor in recognition of her significant contributions to the aesthetic plastic surgery specialty. Highlights of her accomplished resume include: • Completed 3 Fellowships following Plastic Surgery Residency at Northwestern University Medical School: • 1988 Clinicel Fellow Microsurgery and Research Fellow, Southern Illinois University, Springfield, IL • 1989 Clinical Aesthetic Plastic Surgery Fellow, New York University/Manhattan Eye, Ear and Throat (MEETH), New York City • 1989 Clinical Aesthetic Breast Reconstruction Fellow St. Joseph Hospital – Emory University, Atlanta, GA • 1990.2009 Associate Professor of Surgery, Northwestern University Medical School, Chicago, IL • 2009-2016 Clinical Associate Professor of Surgery, Section of Plastic & Reconstructive Surgery, University of Chicago Medicine .2017-2022 Clinical Professor of Surgery, Section of Plastic & Reconstructive Surgery, University of Chicago Medicine • 34 years in private practice and academic appointments • Membero The Aesthete Society: Bond of Directorsand Vice Chala? the Communications Commision (2003 – 2009) • Clinical Editor for Aesthetic Surgery Journal (2006 – 2021) • AS/ Breast Section Editor 2006-2012 • ASJ Section Editor Featured Operative Reports 2012-2021 • 2003.2006 Vice Chair, Communications Commission • 2006-2009 Chair, Communications Commission Six years as a Traveling Professor for The Aesthetic Society • An authority in aesthetic plastic surgery and cosmetic medicine whose focus is patient-centric outcomes research, who is highly sought after as a lecturer and panelist. • Represented The Society and Foundation at the FDA hearings on breast implant safety 2001, 2006, 2013, and 2019 • Many peer reviewed publications of Clinical studies with Level of Evidence 2 on Aesthetic Breast Surgery and Aesthetic Medicine To honor Dr. Casas’ distinguished career and her impact, make a tax-deductible donation to The Aesthetic Foundation and support groundbreaking esthetic research in the process. Donate now www.aserf.org/awarddonate and add a personal message, left in the Comments section, that collected and given to Dr. Casas in the form of a commemorative book.

Carrie Caulkins joined Galderma 6 years ago and recently moved back to the US to lead the Aesthetics Marketing team. She spent the last 5 years in Europe where she oversaw the global fillers franchise, driving overall business strategy, pipeline, and lifecycle management of the Restylane and Sculptra brands. Carrie has broad US and global experience in developing and launching new products based on customer insights, strong cross-functional collaborations, and building of high-performance teams. The past 12 years of her career have focused on medical aesthetics including 6 years at Allergan. She has further held several roles within Medical Affairs at Allergan for facial aesthetics and neurology and took a cosmeceutical product from bench-top to market at an aesthetics start-up business. Carrie earned her MS and PhD in Biomedical Engineering from the University of California, Los Angeles, an MBA from the University of California, Irvine, and a bachelor’s in science degree in biomedical engineering from Brown University.

Dr. Akash Chandawarkar is a Harvard-educated physician, Johns Hopkins–trained plastic and reconstructive surgeon, and fellowship-trained aesthetic surgeon. He is the founder of Mirror Plastic Surgery in St. Petersburg, Florida, a boutique concierge practice offering head-to-toe plastic surgery, injectables, and comprehensive wellness care including peptides and sexual health. He also serves as the Medical Director of Elevate Medical Spa. Dr. Chandawarkar studied neuroscience and nuclear engineering at the Massachusetts Institute of Technology (MIT) before earning his M.D. degree cum laude with Honors in a Special Field from Harvard Medical School in 2014 as part of the Harvard-MIT Division of Health Sciences & Technology (HST) program. He completed a seven-year residency in plastic and reconstructive surgery at Johns Hopkins/University of Maryland, followed by the prestigious Manhattan Eye, Ear & Throat Hospital (MEETH) fellowship in New York City, endorsed by The Aesthetic Society. Recognized by Newsweek America’s Best Plastic Surgeons for multiple consecutive years, Dr. Chandawarkar has built a reputation at the intersection of innovation, technology, and patient care. He is an active researcher and industry collaborator, publishing widely on injectable safety, artificial intelligence in aesthetics, and emerging treatment technologies. His entrepreneurial background includes a Stanford Biodesign Innovation Fellowship and Life Science Angels investing fellowship in Silicon Valley, where he trained in medical device innovation and investing in novel technologies. Originally from the northeast, Dr. Chandawarkar now resides in St. Petersburg with his wife Carly and their daughters Aria and Anika.

Dr. Steven Cohen is a plastic surgeon specializing in aesthetic and regenerative facial surgery. Dr. Cohen focuses on advanced facial rejuvenation techniques such as the deep plane face and deep neck surgery with gland and muscle contouring if needed, rhinoplasty, brow and eye lifts, genioplasty and regenerative and stem cell approaches to facial fat grafting.v Dr. Cohen has a worldwide influence due to his many innovations including the invention of injectable tissue replacement and regenerative facial fat grafting. In addition to holding provisional patents on various other widely used regenerative medicine devices, he hosts surgical demonstrations and educates surgeons at lectures at home and across the globe. He has been recognized by both the International Society of Aesthetic Plastic Surgeons (ISAPS) and the Aesthetic Society (Tiffany Award in 2017) as a leading innovator driving plastic and regenerative surgery into the future. Dr. Cohen has written over 170 publications and has completed three textbooks, most recently a textbook on Regenerative Facial Surgery along with his colleague and co-founder of the London Regenerative Institute, Dr. Tunc Tiryaki. Dr. Cohen is very involved in teaching and has been a Clinical Professor at the University of California, San Diego for over 20 years. He has received 4 “Professor of the Year” awards, including in 2020. Dr. Cohen’s work in Craniofacial Surgery is recognized throughout the world for his inventions and contributions in complex intracranial reconstructive surgery for children with severe birth defects.

Dr. DeLucia is a board-certified obstetrician and gynecologist and has been a fellow of the American College of OB/GYN since 1995. She is a luminary in the field of sexual health and noninvasive sexual wellness treatments. She expanded her practice into aesthetics, specializing in rejuvenation and anti-aging noninvasive procedures. She also has extensive experience in full body and facial rejuvenation treatments. She genuinely cares about her patients, developing a sincere relationship with them as she helps to optimize their quality of health and a longer and more fulfilled life.

Aubrie Dunn is a healthcare executive, entrepreneur, and investor with 25 years of experience building, owning, and operating companies across the healthcare industry. Her background includes nursing homes, hospice, home health, biologics, wound care, surgical care, and medical aesthetics, providing deep operational insight across multiple sectors. Aubrie is the CEO of Revive Distribution, a company she founded six years ago to serve providers in advanced healthcare and medical aesthetics markets. Under her leadership, Revive Distribution has scaled through strategic partnerships, operational excellence, and scaling advanced healthcare solutions. Aubrie attended Brigham Young University, where she was a Division I athlete, an experience that shaped her competitive drive and leadership mindset. She lives with her husband in New York City, with whom they share 3 adult children.

Amber Edwards is the Founder & CEO of EncorVita Health, a platform designed to equip premium aesthetic clinics to deliver evidence-based women’s health and perimenopause care. She is a globally recognized operator in medical aesthetics with more than 20 years of experience building, scaling, and commercializing category-defining brands across pharmaceuticals, medical devices, and physician-dispensed skincare. Amber played a formative role in the early commercial launches of Botox and Juvederm, helping establish and scale two of the most successful products in medical aesthetics history. Her Allergan career included US and International leadership roles in both Aesthetics and Ophthalmology, leading RESTASIS to blockbuster status and later overseeing strategic marketing and execution for the Aesthetics portfolio across all ex-U.S. markets. She went on to serve as Chief Commercial Officer of ALASTIN Skincare, the fastest-growing physician-dispensed skincare brand at the time, where she helped drive rapid scale and brand equity, culminating in a successful acquisition by Galderma. Most recently, Amber was Global CEO of Sinclair, a medical aesthetics company with a portfolio of 16 medical device solutions commercialized in more than 55 countries. Amber began her healthcare career "carrying a bag" as a Parke-Davis sales representative and went on to lead sales training for the women's health division before the company was acquired by Pfizer in 2000. Amber moved to NYC to take on a variety of different marketing roles at Pfizer, including a formative role on the femHRT team, making her return to perimenopause care a true full-circle story.

Dr. Franco is a graduate of Beloit College, where he earned a Bachelor of Science degree in Biochemistry. His passion for medicine led him to the University of Texas Medical Branch at Galveston, where he obtained his Doctor of Medicine degree, marking the beginning of his journey in the world of healthcare. During his residency in Plastic Surgery at Saint Louis University School of Medicine, Dr. Franco demonstrated exceptional dedication and leadership, serving as chief resident from 2010 to 2011. In pursuit of excellence and continuous learning, Dr. Franco embarked on a journey of international training. In 2011, he completed additional training at Chan Gung Hospital in Taiwan, where he focused on microsurgery, particularly in the context of cancer reconstruction. Following this, he pursued a fellowship at Gent University Hospital in Belgium, specializing in breast reconstruction and fat transfer techniques. These experiences enriched his skills and expanded his global perspective on plastic surgery. Dr. Franco’s commitment to education extends to his current role as Clinical Faculty at The University of Texas Dell Medical School. Additionally, he plays a pivotal role as a reviewer for renowned publications like the Aesthetic Journal and Annals of Plastic Surgery, where he evaluates articles submitted by plastic surgeons worldwide for publication. As a testament to his leadership and influence in the plastic surgery community, Dr. Franco currently serves as the president of the Austin Society of Plastic and Reconstructive Surgeons. He is an active member of esteemed professional organizations, including the Texas Society of Plastic Surgeons, the American Society of Plastic Surgeons, and the American Society of Aesthetic Plastic Surgeons. Dr. Franco’s expertise has garnered recognition in various media outlets, including magazines like Miami Shoot, Miami Herald, Med Aesthetics, and HuffPost. His depth of knowledge and insights into aesthetic surgery have made him a sought-after expert in the field. In the digital age, Dr. Franco is a pioneer in sharing knowledge and insights through his hit podcast, “Plastic Surgery Untold.” He also contributes to the growth of the industry by serving as a national trainer for industry leaders such as Revelle Aesthetics, Apex Medical, Bioaesthetics, and Dominion Aesthetics. Dr. Franco’s commitment to education is further demonstrated by his role as a host and instructor for courses at prominent annual meetings of organizations like ASAPS, ASPS, and TSPS. Dr. Franco is on the advisory boards of Realself, Yes Doctor, Bioaesthetics, and Apex Medical. His involvement in these advisory boards contributes to advancing medical knowledge and innovation in the field. Dr. Franco is also the founder of Austin Plastic Surgeon, a thriving practice that has grown from a single provider six years ago to a team of eleven providers across three offices in two cities. Austin Plastic Surgeon won Best Plastic Surgery Center in the 2023 Austin Statesman Austin Best of the Best awards, where Dr. Franco also won Best Plastic Surgeon. His dedication to patient care and quality outcomes has been instrumental in the success of this venture.

Ashley Gordon, MD, is an ASPS & TAS Member plastic surgeon who is board certified by The American Board of Plastic Surgery® and trained specifically in plastic surgery. ASPS members operate only in accredited medical facilities, adhere to a strict code of ethics and fulfill continuing medical education requirements in plastic surgery, including training in patient safety techniques. As your medical partner, Dr. Gordon is dedicated to working with you to achieve your goals.

As one of L.A.’s most trusted plastic surgeons, Dr. Daniel Gould is passionate about bettering patients’ lives through aesthetics. With specialized training in advanced techniques for surgical and non-surgical cosmetic enhancements, Dr. Gould is sought after for his unique combination of expert knowledge, exceptional surgical skills for improving the physical aesthetic, and a reputation for a highly individual level of patient care.

Leigh is a partner in McKinsey’s Boston office and a leader in the Life Sciences, Healthcare, and Private Capital Practices. She helps investors, life sciences companies, and academic and research institutions drive growth and innovation. Her main focus is on accelerating the adoption of new biopharmaceuticals and medical products. Before joining McKinsey, Leigh practiced as a plastic surgeon.

Chia Chi Kao, MD is a board-certified aesthetic plastic and reconstructive surgeon with over fifteen years of experience whom Vogue claims “is single-handedly revolutionizing the future of facelifts”. “My focus is as much on the emotional as the physical. It is not about making someone simply look younger, but giving them the gift of feeling attractive and vibrant. Beauty is timeless.” – Chia Chi Kao, MD Dr. Kao has curated his own specialized techniques for each procedure, enabling him to cause minimal disruption, prevent damage, and maintain the health and quality of the skin, most often improving it. He is also the founder of the KAO Center in Santa Monica, CA and is the creator of the new and revolutionary Ponytail Lift™ and Ponytail Facelift™ procedures.

Mark Kavulich joined Athyrium in 2017 and currently serves as a Partner. He previously served as a Principal and as a Vice President. Since joining Athyrium, Mark has been actively involved with numerous investments, including growth equity and private equity style investments, fixed income and special situations. He participates in all major investment functions including origination, transaction execution, portfolio company development, and monetization events. Mark has experience in both private and public market investing across the U.S. and Europe. His sub-sector experience includes specialty and OTC pharmaceuticals, pharma services, medical devices, healthcare services, and healthcare IT. Prior to joining Athyrium, Mark was a Vice President at Avista Capital Partners, a middle market private equity firm, where he primarily focused on investments in the Healthcare industry, including leveraged buyouts, mergers, acquisitions, and growth equity investments. He formerly served as an Associate at Avista. Prior to Avista, Mark served as an Analyst in the financial sponsors and leveraged finance groups at Morgan Stanley. Mark received a B.S. in Foreign Service with a concentration in International Economics, Finance and Commerce and proficiency in Chinese from Georgetown University.

Ian Li is a Principal on the investment team at 1315 Capital. Prior to investing, Ian was a healthcare management and strategy consultant at Capgemini Consulting and had experience working at Stryker Orthopaedics in the quality engineering department. Ian currently serves on the board of 3B Scientific, CortiCare, and miraDry, and is a board observer for Nutrisense. He previously served on the board of Colorescience (acquired by RoundTable), and was a board observer for Bonafide Health (acquired by Pharmavite). Ian also serves as Co-Chair of the Duke University Philadelphia Alumni Board, is on the board of Philadelphia’s Magic Gardens, and is on the leadership team of Out Investors. Ian received a BSE in Biomedical Engineering from Duke University, with a minor in Economics.

Nadeem Moiz is the Chief Executive Officer of Revance. An avowed growth business leader, Mr. Moiz is inspired by the work of Muhammad Yunus, the Bangladeshi social entrepreneur, banker, economist, civil society leader and Nobel Peace prize laureate, whom he first heard speak at Harvard Business School. Since then, Mr. Moiz has been partnering with leading private equity firms to help emerging growth companies achieve scale by encouraging entrepreneurship and sound business practices. Mr. Moiz is recognized as a strong strategic and operational leader. Prior to joining Revance, Mr. Moiz was the COO and CFO of a home building products company, Select Interior Concepts, that he took public and listed on NASDAQ in 2018. In addition, his experience includes CFO and leadership roles in multiple billion dollar global industrial and automotive companies. He most recently served on the board of Susan G. Komen, the largest non-profit addressing breast cancer support and research, and was also on the board of the Salvation Army and advisory board of International Assist that focused on diabetes in Belize. Mr. Moiz holds a Bachelor of Science in Accounting from the University of Florida, an MBA in finance from Florida A&M University, and Advance Management study at Harvard Business School. He is also a Certified Public Accountant and Certified Global Management Accountant. He lives in Atlanta with his wife and 2 kids, is an avid scuba diver and sailor as he grew up in the Cayman Islands.

Dr. Kiya Movassaghi, MD, DMD, FACS, is a graduate of Harvard Medical School and Harvard Plastic Surgery program and is a board-certified plastic surgeon with over 23 years of experience in Eugene, OR. He specializes in cosmetic and reconstructive surgery. He is the founder of Movassaghi Plastic Surgery and Ziba Medical Spa. He serves as Clinical Assistant Professor of Plastic Surgery at Oregon Health & Science University’s School of Medicine in Portland. Dr. Movassaghi is the director of the Endorsed Aesthetic Fellowship at Movassaghi Plastic Surgery. He is the immediate Past President of The Aesthetic Society (ASAPS), current member of the Executive Committee of The Aesthetic Society and past president of the Northwest Society of Plastic Surgeons (NWSPS). He frequently lectures at residency programs as a visiting professor as well as national and international plastic surgery meetings. He has authored the book “shaping the breast” and published many peer-reviewed articles on facial and breast topics.

Dr. Nahai is internationally recognized as an innovator in the field of plastic surgery, where he has developed and refined countless aesthetic and reconstructive procedures. His contribution to aesthetic (Cosmetic) surgery is extensive including numerous refinements and innovations. As a surgeon, Dr. Nahai is always at the forefront of what is new and exciting in his field. As an accomplished surgeon, known for creating beautiful, elegant results, Dr. Nahai is highly revered for his kindness, patience and ability to deeply understand the desires of his patients.As former Maurice J. Jurkiewicz Chair in Plastic Surgery and Professor of Surgery at Emory University, Dr. Nahai has taught his innovative techniques to plastic surgery residents, who ultimately have been placed throughout the country in private practice and academic programs. Spanning the globe, at both in-person and video conferences, Dr. Nahai shares his expertise and techniques to advance the field of Plastic Surgery at large. Foad Nahai, MD is often referred to by his medical peers as a man of great modesty, and at the same time, is considered to be one of the most respected plastic surgeons not only in the United States but internationally. Having served as both President of the American Society for Aesthetic Plastic Surgery and President of the International Society of Aesthetic Plastic Surgery, has given him an ideal stage to influence the specialty worldwide. In addition to numerous professional honors and awards, Dr. Nahai has been listed in “Best Doctors in America,” “Best Doctors in Atlanta,” and in W Magazine as one of the top plastic surgeons in the world. He has been invited to lecture and demonstrate plastic surgical procedures all over the world.

Audrey Neff brings over a decade of experience in the medical aesthetics and wellness fields, with a deep passion for helping practices achieve maximum success in their business. She currently serves as Chief Marketing Officer for Aviva Aesthetics, a 12-location medical aesthetics practice platform based in the U.S. An international speaker and award-winning, peer-reviewed author by ISPAN, Audrey is also a Galderma GAIN Business Trainer for the U.S. and a global KOL for Merz Aesthetics. She has contributed to numerous market research initiatives and served as faculty for more than 30 medical associations and conferences worldwide. Audrey is also the host of True to Form, a top 3% podcast globally, which features transparent conversations with the most influential voices shaping the future of the rapidly-growing medical aesthetics industry.

Mr. Neumann is a Managing Partner and Co-Founder of LCM, a member of the LCM Investment Committee and is responsible for originating, executing and managing investments across healthcare industry sectors such as healthcare services, life science services, medical device and medical tools and equipment. He is currently a member of the Board of Directors of Beacon Behavioral Holdings, inReach Health, Healthcare Building Solutions, Elixia, Salt Dental Collective, Institutes of Health, Athenix Body Sculpting Institute, and Life Science Connect. He formerly served on the board of American Veterinary Group, Xpress Wellness, and Restoration Behavioral Health Group. He has over 25 years of private equity and corporate finance experience and was a Managing Director at KRG Capital Partners, a private equity firm established in 1998 with ~$4 billion of assets under management. Mr. Neumann also served as a member of KRG Capital’s Fund IV Investment Committee and as a member of the firms Operating Board of Directors. He was also a lead Managing Director and member of the Board of Directors for a number of its portfolio companies. Prior to joining KRG Capital, Mr. Neumann served as a Vice President for a regional investment banking firm (1996 to 1998) and as a Manager in the Corporate Finance Services Group with the San Francisco office of Coopers & Lybrand (1992 to 1996). Mr. Neumann earned a Master of Science degree in Finance and a Bachelor of Science degree in Accounting from the University of Colorado. He is currently a member of the Young Presidents’ Organization and also serves as a director of COPIC Insurance Company.

Dr. Matthew J. Nykiel is a board-certified surgeon and an internationally recognized leader in cosmetic plastic surgery. He is one of the few surgeons to hold this double subspecialty and has completed the prestigious Cosmetic Fellowship endorsed by the American Society for Aesthetic Plastic Surgery (ASAPS), which is the only cosmetic group consisting entirely of board-certified plastic surgeons. Previously a member of the Stanford University Plastic Surgery Faculty and a Stanford alumnus, Dr. Nykiel earned his Medical Degree from Indiana University. He completed an esteemed Plastic Surgery Residency in St. Louis, where he was honored as Administrative Chief Resident and elected to the Graduate Medical Education Committee. Recognized by Doctor’s Choice Awards and Top100 Doctors, Dr. Nykiel is also a sought after certified VASER Liposuction Trainer, sharing his advanced techniques with physicians who visit his office to learn under his expertise.

Dr. Parrish leads the corporate development strategy and operations for Merz Aesthetics. Since joining Merz in 2009, Dr. Parrish has worked in a variety of sales, marketing and business/corporate development roles, including an international assignment at Merz headquarters in Frankfurt, Germany. Dr. Parrish holds a MBA from Cornell University and a doctorate in organic chemistry from the University of California, Santa Barbara.

Serial Entrepreneur and Strategic Advisor specialized in unlocking value at the intersection of Healthcare, FinTech, and MedTech. With two decades of experience, Mr. Rankin has a proven history of scaling early and mid-stage companies, notably co-founding HintMD (Acquired by RVNC) and holding executive leadership roles at ZELTIQ and Solta Medical. Currently, he leads First Place Pediatrics, a mission-driven platform elevating home care for families and clinicians. A former PwC M&A Director and current Family Office founder (Mission Capital), he combines deep financial rigor with an inventor’s mindset to drive innovation across the HealthTech landscape.

Sean Shapiro is the Chief Commercial Officer at MedShift, where he leads the commercial strategy for Velocity Lending, a mobile-first, point-of-sale financing platform that streamlines financing workflows and accelerates time-to-close across the aesthetic and medical industries.

With more than 20 years of experience in the aesthetic healthcare industry, Sean has launched and scaled breakthrough technologies and led global sales organizations for companies including Soliton, Viveve, Merz, Ulthera, and CoolSculpting. His leadership has contributed to multiple high-profile acquisitions and hundreds of millions in device revenue.

Sean holds a B.S. in Marketing and Communications from the University of Arizona.

Dr. Sachin M. Shridharani is a Harvard educated, Johns Hopkins trained, renowned, board-certified plastic surgeon based on Manhattan’s famed Fifth Avenue and the founder of LUXURGERY – The confluence of luxury and aesthetic surgery. Furthermore, he is Associate Clinical Professor of Plastic Surgery at Washington University – St. Louis School of Medicine. His commitment to excellence has earned him several global accolades. Dr. S has authored over 200 publications and abstracts and is recognized as an international authority on aesthetic plastic surgery. Dr. Shridharani serves as an international Global Thought Leader and has lectured on nearly every continent. He serves as a Principal Investigator for clinical trials. Dr. Shridharani is frequently featured in national media outlets including The New York Times, New York Post, Cosmopolitan Magazine, Harper’s Bazaar, NBC, FOX, and ABC. Dr. S serves as the cosmetic surgery expert and Brand Ambassador for Haute Living Magazine.

After a global recruitment effort, Dr. Neinstein sought Dr. Anna Steve to join the growing team of world-class plastic surgeons at Neinstein Plastic Surgery. Dr Anna Steve brings her passion for elegant breast surgery to Neinstein Plastic Surgery. Dr. Anna is distinguished from her peers by her charismatic, participative, and people-oriented approach to life and work. She inspires and motivates people to get behind a challenging and important idea, which for her is purpose-driven breast surgical care. Dr. Anna focuses on optimizing women’s sense of self and femininity through sophisticated breast surgery. Whether you are hoping to add a little extra volume, remove volume or address changes of pregnancy, breastfeeding, gravity, or weight fluctuation, she will help individualize your journey to discover your best self. She grew up in a 600 person town in Saskatchewan Canada. Here she learned to be steady at all times, especially in stressful situations. Her calm demeanor helps patients feel at ease and cared for. She is a wife and mother of two which brings familiarity of circumstances and emotions to her patients – helping strengthen the therapeutic bond. As a working mother of two and fitness enthusiast, she shares an intimate understanding of the need for minimal downtime and rapid recovery during the patient experience. She also prioritizes a minimal-scar approach to breast augmentation to achieve the most refined results. Her interest in certainty and science brought Dr. Anna to medical school and through her surgical training. Intellectual curiosity had her pursue two extra subspecialty fellowships at NYU and in Canada before starting her full-time practice at Neinstein Plastic Surgery.